165 related articles for article (PubMed ID: 2980988)
1. Transplacental pharmacokinetics of teratogenic doses of etretinate and other aromatic retinoids in mice.
Reiners J; Löfberg B; Kraft JC; Kochhar DM; Nau H
Reprod Toxicol; 1988; 2(1):19-29. PubMed ID: 2980988
[TBL] [Abstract][Full Text] [Related]
2. Teratogenicity of the 13-cis and all-trans-isomers of the aromatic retinoid etretin: correlation to transplacental pharmacokinetics in mice during organogenesis after a single oral dose.
Löfberg B; Chahoud I; Bochert G; Nau H
Teratology; 1990 Jun; 41(6):707-16. PubMed ID: 2141193
[TBL] [Abstract][Full Text] [Related]
3. Biotransformation of etretinate and developmental toxicity of etretin and other aromatic retinoids in teratogenesis bioassays.
Kochhar DM; Penner JD; Minutella LM
Drug Metab Dispos; 1989; 17(6):618-24. PubMed ID: 2575497
[TBL] [Abstract][Full Text] [Related]
4. Teratogenicity of steady-state concentrations of etretinate and metabolite acitretin maintained in maternal plasma and embryo by intragastric infusion during organogenesis in the mouse: a possible model for the extended elimination phase in human therapy.
Löfberg B; Reiners J; Spielmann H; Nau H
Dev Pharmacol Ther; 1990; 15(1):45-51. PubMed ID: 2147001
[TBL] [Abstract][Full Text] [Related]
5. Teratogenicity of etretinate during early pregnancy in the rat and its correlation with maternal plasma concentrations of the drug.
Agnish ND; Vane FM; Rusin G; DiNardo B; Dashman T
Teratology; 1990 Jul; 42(1):25-33. PubMed ID: 2144063
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetics of etretin and etretinate during long-term treatment of psoriasis patients.
Larsen FG; Jakobsen P; Larsen CG; Kragballe K; Nielsen-Kudsk F
Pharmacol Toxicol; 1988 Mar; 62(3):159-65. PubMed ID: 2967472
[TBL] [Abstract][Full Text] [Related]
7. Influence of pregnancy on the pharmacokinetic disposition of two aromatic retinoids (etretinate and acitretin) in the rat. I. Intravenous studies.
Brouwer KR; McNamara PJ
Drug Metab Dispos; 1989; 17(6):646-51. PubMed ID: 2575501
[TBL] [Abstract][Full Text] [Related]
8. In vitro embryotoxicity and teratogenic potential of etretinate and etretin.
Bechter R; Hall L
Toxicol In Vitro; 1987; 1(4):225-31. PubMed ID: 20702367
[TBL] [Abstract][Full Text] [Related]
9. Low teratogenicity of 13-cis-retinoic acid (isotretinoin) in the mouse corresponds to low embryo concentrations during organogenesis: comparison to the all-trans isomer.
Kraft JC; Kochhar DM; Scott WJ; Nau H
Toxicol Appl Pharmacol; 1987 Mar; 87(3):474-82. PubMed ID: 3470977
[TBL] [Abstract][Full Text] [Related]
10. Acitretin : A Review of its Pharmacology and Therapeutic Use.
Pilkington T; Brogden RN
Drugs; 1992 Apr; 43(4):597-627. PubMed ID: 28421560
[TBL] [Abstract][Full Text] [Related]
11. Transplacental pharmacokinetics and teratogenicity of a single dose of retinol (vitamin A) during organogenesis in the mouse.
Eckhoff C; Löfberg B; Chahoud I; Bochert G; Nau H
Toxicol Lett; 1989 Aug; 48(2):171-84. PubMed ID: 2772923
[TBL] [Abstract][Full Text] [Related]
12. UV-induced isomerization of oral retinoids in vitro and in vivo in hairless mice.
Berne B; Rollman O; Vahlquist A
Photodermatol Photoimmunol Photomed; 1990 Aug; 7(4):146-52. PubMed ID: 2150173
[TBL] [Abstract][Full Text] [Related]
13. Retinoid metabolism and transplacental pharmacokinetics in the cynomolgus monkey following a nonteratogenic dosing regimen with all-trans-retinoic acid.
Tzimas G; Nau H; Hendrickx AG; Peterson PE; Hummler H
Teratology; 1996 Nov; 54(5):255-65. PubMed ID: 9035347
[TBL] [Abstract][Full Text] [Related]
14. Single versus multiple dose administration of all-trans-retinoic acid during organogenesis: differential metabolism and transplacental kinetics in rat and rabbit.
Collins MD; Tzimas G; Bürgin H; Hummler H; Nau H
Toxicol Appl Pharmacol; 1995 Jan; 130(1):9-18. PubMed ID: 7839374
[TBL] [Abstract][Full Text] [Related]
15. Influence of pregnancy on the pharmacokinetic disposition of two aromatic retinoids (etretinate and acitretin) in the rat. II. Single and multiple oral dosing studies.
Brouwer KR; McNamara PJ
Drug Metab Dispos; 1989; 17(6):652-5. PubMed ID: 2575502
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetic assessment of teratologically effective concentrations of an endogenous retinoic acid metabolite.
Satre MA; Penner JD; Kochhar DM
Teratology; 1989 Apr; 39(4):341-8. PubMed ID: 2749577
[TBL] [Abstract][Full Text] [Related]
17. Transplacental pharmacokinetics of a synthetic retinoid which is not bound by mouse embryonic cellular retinoic acid-binding protein.
Sass JO; Hartmann J; Chahoud I; Shroot B; Nau H
Toxicol Lett; 1995 Jan; 75(1-3):159-68. PubMed ID: 7863522
[TBL] [Abstract][Full Text] [Related]
18. Single dose pharmacokinetics of etretin and etretinate in psoriatic patients.
Larsen FG; Jakobsen P; Larsen CG; Nørgaard A; Kragballe K; Nielsen-Kudsk F
Pharmacol Toxicol; 1987 Aug; 61(2):85-8. PubMed ID: 2959917
[TBL] [Abstract][Full Text] [Related]
19. Teratogenicity and transplacental pharmacokinetics of 13-cis-retinoic acid in rabbits.
Eckhoff C; Chari S; Kromka M; Staudner H; Juhasz L; Rudiger H; Agnish N
Toxicol Appl Pharmacol; 1994 Mar; 125(1):34-41. PubMed ID: 8128493
[TBL] [Abstract][Full Text] [Related]
20. Teratogenicity and placental transfer of all-trans-, 13-cis-, 4-oxo-all-trans-, and 4-oxo-13-cis-retinoic acid after administration of a low oral dose during organogenesis in mice.
Creech Kraft J; Löfberg B; Chahoud I; Bochert G; Nau H
Toxicol Appl Pharmacol; 1989 Aug; 100(1):162-76. PubMed ID: 2763297
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
